This Article Full Text Full Text (PDF) Purchase Article View Shopping Cart Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Kooijman, R. Articles by Hooghe-Peters, E. Search for Related Content PubMed PubMed Citation Articles by Kooijman, R. Articles by Hooghe-Peters, E.

IGF-I Inhibits Spontaneous Apoptosis in Human Granulocytes

Department of Pharmacology, Medical School, Vrije Universiteit Brussel, B-1090 Brussels, Belgium

Address all correspondence and requests for reprints to: Ron Kooijman, Department of Pharmacology, Medical School, Free University of Brussels (VUB), Laarbeeklaan 103, B-1090 Brussels, Belgium. E-mail: . rkooi{at}farc.vub.ac.be

Granulocytes are key cells in inflammatory processes that are recruited to sites of inflammation by chemoattractants such as IL-8 produced by neutrophils and monocytes. Programmed cell death (apoptosis) of granulocytes and subsequent recognition and phagocytosis by macrophages is a crucial mechanism for resolution of inflammation. Because IGF-I is a potent antiapoptotic factor, we addressed the effects of IGF-I on in vitro apoptosis of human peripheral blood granulocytes. We detected 1390 ± 467 IGF-I receptors with a dissociation constant of 2.3 ± 0.9 nM on purified granulocytes. Using microscopical analysis, annexin V binding assays to detect relocation of phosphatidylserine to the cell surface, and DNA fragmentation assays, we showed that IGF-I inhibits spontaneous apoptosis of granulocytes in serum-free culture by 32–45%. IGF-I did not modulate the secretion of IL-6, TNF, and IL-8 by granulocytes, but IL-8 secretion by peripheral blood mononuclear cells was enhanced by 40%. These observations indicate that IGF-I may promote granulocyte functions by increasing granulocyte longevity.

This article has been cited by other articles:

				M. Sohmiya, I. Kanazawa, and Y. Kato Effect of recombinant human GH on circulating granulocyte colony-stimulating factor and neutrophils in patients with adult GH deficiency Eur. J. Endocrinol., February 1, 2005; 152(2): 211 - 215. [Abstract] [Full Text] [PDF]

				A. Hartnell, A. Heinemann, D. M. Conroy, R. Wait, G. J. Sturm, M. Caversaccio, P. J. Jose, and T. J. Williams Identification of Selective Basophil Chemoattractants in Human Nasal Polyps as Insulin-Like Growth Factor-1 and Insulin-Like Growth Factor-2 J. Immunol., November 15, 2004; 173(10): 6448 - 6457. [Abstract] [Full Text] [PDF]

				R. Kooijman and A. Coppens Insulin-like growth factor-I stimulates IL-10 production in human T cells J. Leukoc. Biol., October 1, 2004; 76(4): 862 - 867. [Abstract] [Full Text] [PDF]

				A. Veronelli, M. Laneri, R. Ranieri, D. Koprivec, D. Vardaro, M. Paganelli, F. Folli, and A. E. Pontiroli White Blood Cells in Obesity and Diabetes: Effects of weight loss and normalization of glucose metabolism Diabetes Care, October 1, 2004; 27(10): 2501 - 2502. [Full Text] [PDF]

				P. Fischer-Posovszky, H. Tornqvist, K.-M. Debatin, and M. Wabitsch Inhibition of Death-Receptor Mediated Apoptosis in Human Adipocytes by the Insulin-Like Growth Factor I (IGF-I)/IGF-I Receptor Autocrine Circuit Endocrinology, April 1, 2004; 145(4): 1849 - 1859. [Abstract] [Full Text] [PDF]